Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Aptose Biosciences Inc. (T.APS) had Debt to Equity Ratio of -0.02 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-7.06M |
|
-- |
|
-- |
|
-- |
|
-6.77M |
|
-- |
|
-7.06M |
|
-7.06M |
|
-7.06M |
|
-7.06M |
|
-7.06M |
|
-7.06M |
|
-6.77M |
|
-6.62M |
|
2.55M |
|
2.55M |
|
-2.77 |
|
-2.77 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
8.74M |
|
-- |
|
-- |
|
-- |
|
35.53M |
|
-26.79M |
|
-26.79M |
|
-26.79M |
|
2.55M |
|
| Cash Flow Statement Financials | |
-22.25M |
|
-- |
|
15.26M |
|
9.24M |
|
2.26M |
|
-6.98M |
|
0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.02 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
26.34% |
|
26.34% |
|
-80.79% |
|
26.34% |
|
-10.50 |
|
-8.72 |
|
-8.72 |
|